Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Keratosis, Actinic 7Carcinoma, Basal Cell 3Warts 1Carcinoma, Squamous Cell 1Bowen's Disease 1

Interventions

N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2Cryotherapy 2Cholecalciferol 2Cantharidin 22-Propanol 2plerixafor 1methyl 5-aminolevulinate 1green tea extract polyphenone E 1VP-102 1Sugars 1Photochemotherapy 1PRA1 protein, Candida albicans 1Measles-Mumps-Rubella Vaccine 1Maltose 1Interferon-alpha 1Human Papillomavirus Recombinant Vaccine nonavalent 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Exercise 1Ethanol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Warts × methyl 5-aminolevulinate × Clear all
NCT00472459 2025-04-18

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

Galderma R&D

Phase 3 Completed
82 enrolled 20 charts
Dermatologic

Bowen's Disease, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Warts, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡